Erschienen in:

01.10.2001 | ORIGINAL ARTICLE

Early phase II study of S-1, a new oral fluoropyrimidine, for advanced non-small-cell lung cancer

verfasst von: K. Furuse, M. Kawahara, K. Hasegawa, S. Kudoh, M. Takada, T. Sugiura, Y. Ichinose, M. Fukuoka, Y. Ohashi, H. Niitani, for the S-1 Cooperative Study Group (Lung Cancer Working Group)

Erschienen in: International Journal of Clinical Oncology | Ausgabe 5/2001